| Pomalidomide investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 56show all (up to 200) |
|---|
| → investigated in trials for | Multiple Myelomahematologic_malignancy 185 trials (77 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Multiple Myeloma | 185 | Observed | clinicaltrials | graph → |
| → investigated in trials for | AL Amyloidosishematologic_malignancy 5 trials (4 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | AL Amyloidosis | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Myeloproliferative Neoplasmhematologic_malignancy 4 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Myeloproliferative Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Acute Myeloid Leukemia 3 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Acute Myeloid Leukemia | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Diffuse Large B-Cell Lymphoma 3 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Diffuse Large B-Cell Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Kaposi Sarcomacancer 3 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Kaposi Sarcoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Non-Hodgkin Lymphoma 3 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Plasma Cell Neoplasmhematologic_malignancy 3 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Plasma Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Primary Central Nervous System Lymphoma 3 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Primary Central Nervous System Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Neoplasm 2 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Neoplasm 2 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Primary Myelofibrosishematologic_malignancy 2 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Primary Myelofibrosis | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Skin Kaposi Sarcoma 2 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Skin Kaposi Sarcoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Smoldering Multiple Myelomahematologic_malignancy 2 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Smoldering Multiple Myeloma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Waldenstrom Macroglobulinemia 2 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Waldenstrom Macroglobulinemia | 2 | Observed | clinicaltrials | graph → |